-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Kymera Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2019 to Q3 2024.
- Kymera Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $14.9M, a 27.9% increase year-over-year.
- Kymera Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $52.1M, a 26.7% increase year-over-year.
- Kymera Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $43.1M, a 21.5% increase from 2022.
- Kymera Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $35.5M, a 42.1% increase from 2021.
- Kymera Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $25M, a 381% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)